 | Up a level |
Chabriat, Hugues; Bassetti, Claudio L.; Marx, Ute; Audoli-Inthavong, Marie-Laure; Sors, Aurore; Lambert, Estelle; Wattez, Marine; Hermann, Dirk M (2020). Safety and efficacy of GABAA α5 antagonist S44819 in patients with ischaemic stroke: a multicentre, double-blind, randomised, placebo-controlled trial. The lancet. Neurology, 19(3), pp. 226-233. Elsevier 10.1016/S1474-4422(20)30004-1
Chabriat, Hugues; Bassetti, Claudio L.; Marx, Ute; Picarel-Blanchot, Françoise; Sors, Aurore; Gruget, Celine; Saba, Barbara; Wattez, Marine; Audoli, Marie-Laure; Hermann, Dirk M. (2020). Randomized Efficacy and Safety Trial with Oral S 44819 after Recent ischemic cerebral Event (RESTORE BRAIN study): a placebo controlled phase II study. Trials, 21(1), p. 136. BioMed Central 10.1186/s13063-020-4072-2
Hermann, Dirk M; Saba, Barbara; Sors, Aurore; Bassetti, Claudio L. (2019). Preclinical concepts and results with the GABAA antagonist S44819 in a mouse model of middle cerebral artery occlusion. Neural Regeneration Research, 14(9), pp. 1517-1518. Medknow 10.4103/1673-5374.255963
